Prostate Cancer

Investigation of the halo-artifact in 68Ga-PSMA-11-PET/MRI. August 21, 2017

Chemotherapy for oligometastatic prostate cancer. August 21, 2017

Association between dietary phytoestrogens intakes and prostate cancer risk in Sicily. August 21, 2017

Radical prostatectomy innovation and outcomes at military and civilian institutions. August 21, 2017

Novel androgen axis systemic therapies for metastatic hormone-sensitive prostate cancer. August 21, 2017

Radiotherapy as metastasis-directed therapy for oligometastatic prostate cancer. August 21, 2017

Radiation therapy to the primary in metastatic prostate cancer: palliation only or altering tumor biology? August 21, 2017

Preclinical Evaluation of Intravesical Cisplatin Nanoparticles for Non-Muscle-Invasive Bladder Cancer. August 21, 2017

Pretreatment Serum Cystatin C Levels Predict Renal Function, but Not Tumor Characteristics, in Patients with Prostate Neoplasia. August 20, 2017

Cancer Incidence Among Patients of the U.S. Veterans Affairs Health Care System: 2010 Update. August 20, 2017

Statistical shortcut could speed evaluation of prostate cancer drugs. August 20, 2017

Risk adapted dose-intensified postoperative radiation therapy in prostate cancer patients using a simultaneous integrated boost technique applied with helical Tomotherapy. August 18, 2017

Neuroendocrine Differentiation in Metastatic Conventional Prostate Cancer Is Significantly Increased in Lymph Node Metastases Compared to the Primary Tumors. August 18, 2017

Diverse Immunoprofile of Ductal Adenocarcinoma of the Prostate with an Emphasis on the Prognostic Factors. August 18, 2017

Individual and mutual predictors of marital satisfaction among prostate cancer patients and their spouses. August 18, 2017

Prostate-specific antigen screening: An update of physician beliefs and practices. August 18, 2017

Comparison of Multiparametric and Biparametric MRI in First Round Cognitive Targeted Prostate Biopsy in Patients with PSA Levels under 10 ng/mL. August 18, 2017

Prostate-Specific Antigen 5 Years following Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer: An Ablative Procedure? August 18, 2017

Engaging patients in complex clinical decision-making: Successes, pitfalls, and future directions. August 18, 2017

The cost-effectiveness of active surveillance compared to watchful waiting and radical prostatectomy for low risk localised prostate cancer. August 18, 2017

Page 1 of 738

E-Newsletters

Stay Connected

Signup to receive urology industry news and updates via email